FDA Approves Myhibbin for Prophylaxis of Organ Rejection in Adult, Pediatric Transplant Recipients

1. Azurity Pharmaceuticals, Inc announces FDA approval of Myhibbin™ (mycophenolate mofetil oral suspension). News release. · 2. Organ donation …